The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cell

• Publication date

  1996-08-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-8674(00)80116-6PMID 8756725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The p21RAS Farnesyltransferase α Subunit in TGF-β and Activin Signaling

  1996cited by this paper
• Developmental expression of a candidate müllerian inhibiting substance type II receptor.

  1996cited by this paper
• The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.

  1996cited by this paper
• Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling.

  1996cited by this paper
• TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.

  1995cited by this paper
• GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex.

  1995cited by this paper
• Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex

  1995cited by this paper
• Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex

  1995cited by this paper
• Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.

  1995cited by this paper
• Control of p70 S6 kinase by kinase activity of FRAP in vivo

  1995cited by this paper
• Control of p70 S6 kinase by kinase activity of FRAP in vivo

  1995cited by this paper
• Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.

  1995cited by this paper
• Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex

  1994cited by this paper
• The TGF-beta family and its composite receptors.

  1994cited by this paper
• Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12.

  1994cited by this paper
• The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.

  1994cited by this paper
• A transforming growth factor beta type I receptor that signals to activate gene expression.

  1994cited by this paper
• FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818.

  1994cited by this paper
• RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.

  1994cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Mechanism of activation of the TGF-β receptor

  1994cited by this paper
• A mammalian protein targeted by G1-arresting rapamycin–receptor complex

  1994cited by this paper
• The TGF-β family and its composite receptors

  1994cited by this paper
• Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila.

  1994cited by this paper
• TGF-beta receptors and actions.

  1994cited by this paper
• Characterization of type I receptors for transforming growth factor-beta and activin.

  1994cited by this paper
• The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-beta superfamily.

  1994cited by this paper
• Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.

  1994cited by this paper
• Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

  1993cited by this paper
• Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

  1993cited by this paper
• Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

  1993cited by this paper
• Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor‐β type II receptor family

  1993cited by this paper
• Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.

  1993cited by this paper
• Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)

  1993cited by this paper
• A composite FKBP12-FK506 surface that contacts calcineurin

  1993cited by this paper
• TGF beta signals through a heteromeric protein kinase receptor complex.

  1992cited by this paper
• Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.

  1992cited by this paper
• Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

  1992cited by this paper
• The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin

  1992cited by this paper
• Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

  1992cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Growth factor signaling by receptor tyrosine kinases.

  1992cited by this paper
• Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

  1992cited by this paper
• Expression cloning of an activin receptor, a predicted transmembrane serine kinase.

  1991cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

  1990cited by this paper
• TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights

  1990cited by this paper
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

  1989cited by this paper
• A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

  1989cited by this paper
• Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.

  1985cited by this paper
• The epithelial-mesenchymal interface of the male rate Mullerian duct: loss of basement membrane integrity and ductal regression.

  1982cited by this paper
• Programmed cell death in the Müllerian duct induced by Müllerian inhibiting substance.

  1977cited by this paper
• A graded organ culture assay for the detection of Mullerian inhibiting substance.

  1977cited by this paper

• Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid

  2025cites this paper
• Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular Therapies

  2025cites this paper
• The role of FK506-binding protein 12 in cancer: from biology to clinical application.

  2025cites this paper
• FK506 enhances bone morphogenetic protein 9-induced cementoblast differentiation in human cementoblast-lineage cells.

  2025cites this paper
• Tacrolimus and diabetic rodent models

  2025cites this paper
• SMAD5 phosphorylation by ALK1 is modulated by the interaction of the spike protein of SARS-CoV-2 and angiotensin-converting enzyme 2.

  2025cites this paper
• Identification of Stable Reference Genes for RT-qPCR in Golden Syrian Hamster under Vaccination and Infection Conditions

  2025cites this paper
• Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice

  2025cites this paper
• The BMP Signaling Pathway: Bridging Maternal-Fetal Crosstalk in Early Pregnancy

  2025cites this paper
• Rapamycin exerts neuroprotective effects by inhibiting FKBP12 instead of mTORC1 in the mouse model of Parkinson's disease.

  2025cites this paper
• Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma

  2025cites this paper
• Point-of-Care Tests via Pollen-Based Nanoplasmonic Chips Combined with a Synthetic Receptor for FKBP12 Biomarker Detection at a Single-Molecule Level

  2025cites this paper
• Wide‐ranging genetic variation in sensitivity to rapamycin in Drosophila melanogaster

  2024cites this paper
• Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification

  2024cites this paper
• LRG1 Loss Effectively Restrains Glomerular TGF-β Signaling to Attenuate Diabetic Kidney Disease.

  2024cites this paper
• Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer

  2024cites this paper
• A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo.

  2024cites this paper
• Unraveling modulation effects on albumin synthesis and inflammation by Striatin, a bioactive protein fraction isolated from Channa striata: In silico proteomics and in vitro approaches

  2024cites this paper
• The high FKBP1A expression in WBCs as a potential screening biomarker for pancreatic cancer

  2024cites this paper
• Human ACVR1C missense variants that correlate with altered body fat distribution produce metabolic alterations of graded severity in knock-in mutant mice

  2024cites this paper
• Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte

  2023cites this paper
• Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor

  2023cites this paper
• FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy

  2023influential citation
• In silico identification of potential PvFKBP35 inhibitors from Entadrophragma angolense Limonoids extracts as antimalarial agents

  2023cites this paper
• Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma

  2023cites this paper
• FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells

  2023cites this paper
• SPI1 activates TGF‐β1/PI3K/Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells

  2023cites this paper
• Functional comparison of human ACVR1 and zebrafish Acvr1l FOP‐associated variants in embryonic zebrafish

  2023cites this paper
• Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression

  2022cites this paper
• Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics

  2022cites this paper
• Molecular biology of apoptotic, necrotic, and necroptotic cell death

  2022cites this paper
• Tacrolimus Up-regulates Expression of TGFβ Receptor Type II via ERK, Providing Protection Against Intestinal Epithelial Injury

  2022cites this paper
• The versatility and paradox of BMP signaling in endothelial cell behaviors and blood vessel function

  2022cites this paper
• Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting.

  2022cites this paper
• Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?

  2021cites this paper
• Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders

  2021cites this paper
• Break Away: FKBP12 sequestration as a target for increasing BMP activity.

  2021cites this paper
• ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex

  2021cites this paper
• Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva

  2021cites this paper
• Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update

  2021cites this paper
• Induced Dimerization Tools to Deplete Specific Phosphatidylinositol Phosphates.

  2021cites this paper
• Inhibition of Histone Methyltransferase EZH2 Suppresses Endometriotic Vesicle Development in a Rat Model of Endometriosis

  2020cites this paper
• Structural Perspective of BMP ligands and Signaling.

  2020cites this paper
• The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation

  2020cites this paper
• Association of rs12997 variant in the ACVR1 gene: a member of bone morphogenic protein signaling pathway with primary open-angle glaucoma in a Saudi cohort

  2020cites this paper
• Receptor binding competition: A paradigm for regulating TGF-β family action.

  2020cites this paper
• Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling

  2020cites this paper
• Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.

  2020cites this paper
• TGF-β Signaling

  2020cites this paper
• Cardiac Excitation and Contraction: Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12

  2020cites this paper
• The Roles of TGF-β Signaling in Cerebrovascular Diseases

  2020cites this paper
• Signaling pathways regulating hepcidin.

  2019cites this paper
• Activation of BMP Signaling by FKBP12 Ligands Synergizes with Inhibition of CXCR4 to Accelerate Wound Healing.

  2019cites this paper
• Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12.

  2019cites this paper
• FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer

  2019cites this paper
• Etude de l'implication des acides sialiques dans la régulation de la fusion myoblastique

  2019cites this paper
• Structural biology of the TGFβ family

  2019cites this paper
• Specification of BMP Signaling

  2019cites this paper
• Receptors for Targeting Growth Factors for Treatment of Cancers

  2019cites this paper
• One-step Heck Reaction Generates Nonimmunosuppressive FK506 Analogs for Pharmacological BMP Activation.

  2019cites this paper
• ACVR1 Function in Health and Disease

  2019cites this paper
• The Horizon of a Therapy for Rare Genetic Diseases: A “Druggable” Future for Fibrodysplasia Ossificans Progressiva

  2018cites this paper
• Zinc and Zinc Transporters: Novel Regulators of Ventricular Myocardial Development

  2018cites this paper
• Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations.

  2018cites this paper
• Rapamycin activates TGF receptor independently of its ligand: implications for endothelial dysfunction.

  2018cites this paper
• Recent Topics in Fibrodysplasia Ossificans Progressiva

  2018cites this paper
• Direct interaction between Smad 3 , APC 10 , CDH 1 and HEF 1 in proteasomal degradation of HEF 1

  2018cites this paper
• TGF-β receptors: In and beyond TGF-β signaling.

  2018cites this paper
• Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model

  2018cites this paper
• Fibrodysplasia (Myositis) Ossificans Progressiva

  2018cites this paper
• Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.

  2018cites this paper
• Smad‐independent TGF‐&bgr;2 signaling pathways in human trabecular meshwork cells

  2017cites this paper
• Variable signaling activity by FOP ACVR1 mutations.

  2017cites this paper
• BMP Signaling in Fibrodysplasia Ossificans Progressiva, a Rare Genetic Disorder of Heterotopic Ossification

  2017cites this paper
• Peptidyl-prolyl isomerase (PPIase): an emerging area in tumor biology

  2017cites this paper
• Radboud Repository of the Radboud University Nijmegen

  2017cites this paper
• Opposite effects of Activin type 2 receptor ligands on cardiomyocyte proliferation during development and repair

  2017cites this paper
• The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

  2017cites this paper
• Overlapping roles of Iroquois Homeobox Genes 3 and 4 in the Compaction of the Ventricular Myocardium

  2017cites this paper
• Novel In Vitro Assay Models to Study Osteogenesis and Chondrogenesis for Human Skeletal Disorders

  2017cites this paper
• Doxycycline attenuates paraquat-induced pulmonary fibrosis by downregulating the TGF-β signaling pathway.

  2017cites this paper
• Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.

  2016cites this paper
• The Discovery and Early Days of TGF-β: A Historical Perspective.

  2016cites this paper
• Title TGF-beta Signaling from Receptors to Smads Permalink

  2016cites this paper
• Biological relevance of Hsp90‐binding immunophilins in cancer development and treatment

  2016cites this paper
• FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2

  2016cites this paper
• Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies

  2016cites this paper
• TGF-β Signaling from Receptors to Smads.

  2016cites this paper
• TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

  2016cites this paper
• Signaling Receptors for TGF-β Family Members.

  2016cites this paper
• Pleiotropic roles in cancer biology for multifaceted proteins FKBPs.

  2015cites this paper
• FKBPL: a marker of good prognosis in breast cancer

  2015cites this paper
• Immunophilins: Structures, Mechanisms and Ligands.

  2015cites this paper
• FK506-Binding Protein 12 Modulates μ-Opioid Receptor Phosphorylation and Protein Kinase Cε–Dependent Signaling by Its Direct Interaction with the Receptor

  2014cites this paper
• Critical roles of miRNA-mediated regulation of TGFβ signalling during mouse cardiogenesis.

  2014cites this paper
• Establishment of a Split-LUX Assay to Determine Protein Interaction of the BMP-Receptor mAlk2R206H (FOP Mutant) with the Rapamycin-Associated Protein FKBP12

  2014cites this paper
• Régulations de la sécrétion et de l’activité biologique de la protéine Tat du VIH-1 : rôles de la palmitoylation et de Gag

  2014cites this paper
• Structural Studies of the Ryanodine Receptor and Its Binding Protein, Calstabin

  2014cites this paper
• Crystal structure of Plasmodium vivax FK506‐binding protein 25 reveals conformational changes responsible for its noncanonical activity

  2014cites this paper
• ALK5 and ALK1 Play Antagonistic Roles in Transforming Growth Factor β-Induced Podosome Formation in Aortic Endothelial Cells

  2014cites this paper